Case 2:14-cv[removed]FSH-MAH Document 1 Filed[removed]Page 1 of 16 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520

First Page		Document Content
Date: 2014-06-25 04:57:47 Patent infringement United States patent law Phentermine/topiramate Patent Generic drug Actavis Food and Drug Administration Pharmaceutical sciences Pharmacology Medicine		Case 2:14-cv[removed]FSH-MAH Document 1 Filed[removed]Page 1 of 16 PageID: 1 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza, Suite 1520 Add to Reading List Source URL: patentdocs.typepad.com Download Document from Source Website File Size: 189,60 KB Share Document on Facebook

	Federal Register / Vol. 83, NoFriday, March 16, Proposed Rules Food and Drug Administration 21 CFR Part 1130 DocID: 1xVJS - View Document
	What is a Vulnerability Disclosure Policy and Why You Need One VDPs work and they protect assets. That’s why the U.S. Department of Justice, the European Commission, and the U.S. Food & Drug Administration recommend th DocID: 1xVfx - View Document
	Notice to Industry: Additional Tobacco Products Now Regulated by the Food and Drug Administration DocID: 1xVey - View Document
	DEPARTMENT OF HEALTH AND HUMAN S ERVICES _________________________________________________________________________________________________________ Food and Drug Administration Center for T obacco Products 9200 Corporate DocID: 1xUvW - View Document
	DEPARTMENT OF HEALTH AND HUMAN SERVICES _________________________________________________________________________________________________________ Food and Drug Administration Center for Tobacco ProductsNew Hampshi DocID: 1xTPU - View Document